SSRIs-Test-depression

SSRIs-Test-depression is a selective serotonin reuptake inhibitor (SSRI) being developed by Test for the treatment of depression. As a member of the SSRI class, it is designed to inhibit the serotonin transporter (SERT), thereby preventing the reuptake of serotonin into the presynaptic neuron. This mechanism increases the extracellular concentration of serotonin in the synaptic cleft, enhancing serotonergic neurotransmission and alleviating symptoms of major depressive disorder. While the name and developer suggest this is a test-stage or hypothetical candidate, its pharmacological profile aligns with standard small molecule interventions for mood disorders.